Hydroxy-PEG3-t-butylester
- CAS NO.:133803-81-3
- Empirical Formula: C11H22O5
- Molecular Weight: 234.29
- MDL number: MFCD20926380
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 09:27:42
What is Hydroxy-PEG3-t-butylester?
Description
Hydroxy-PEG2-t-butyl ester is a PEG linker containing a hydroxyl group with a t-butyl ester. The hydrophilic PEG spacer increases solubility in aqueous media. The hydroxyl group enables further derivatization or replacement with other reactive functional groups. The t-butyl protected carboxyl group can be deprotected under acidic conditions.
The Uses of Hydroxy-PEG3-t-butylester
Hydroxy-PEG2-(CH2)2-Boc is an ADC linker for the synthesis of antibody drug conjugates (ADC), Hydroxy-PEG2-(CH2)2-Boc is derived from patent WO2004008101A2 (compound 196). Hydroxy-PEG2-(CH2)2-Boc can also be used as a PROTAC linker for PROTAC synthesis.
in vitro
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
Properties of Hydroxy-PEG3-t-butylester
| Boiling point: | 321.8±22.0 °C(Predicted) |
| Density | 1.046±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Soluble in DMSO |
| pka | 14.36±0.10(Predicted) |
| form | clear liquid |
| color | Colorless to Almost colorless |
Safety information for Hydroxy-PEG3-t-butylester
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H312:Acute toxicity,dermal H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H332:Acute toxicity,inhalation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for Hydroxy-PEG3-t-butylester
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineRelated products of tetrahydrofuran








You may like
-
Hydroxy-peg2-t-butyl ester 96% CAS 133803-81-3View Details
133803-81-3 -
Hydroxy-PEG2-t-butyl ester >99% (GC) CAS 133803-81-3View Details
133803-81-3 -
PEG3-carboxylic Acid tert-Butyl Ester CAS 133803-81-3View Details
133803-81-3 -
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
118-23-0 NLT 95%View Details
118-23-0 -
573704-41-3 NLT 95%View Details
573704-41-3
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

